U.S. Industrial REITs Stock News

Cerence (CRNC) opened Q1 2026 with total revenue of US$115.1 million, Basic EPS of a US$0.12 loss, and net income excluding extra items of a US$5.2 million loss, while the trailing 12 months show Basic EPS of roughly US$0.01 and net income excluding extra items of about US$0.3 million. Over recent quarters the company has seen revenue move from US$50.9 million in Q1 2025 to US$115.1 million in Q1 2026, alongside Basic EPS shifting from a US$0.57 loss to a US$0.12 loss and trailing 12 month...

If you are wondering whether Sarepta Therapeutics at US$20.80 is starting to look like value or still carries too much risk, the recent share price and fundamentals give you a lot to weigh up. The stock has been under pressure, with returns of 0.4% decline over 7 days, 9.9% decline over 30 days, 2.4% decline year to date, 43.0% decline over 1 year and 82.7% decline over 3 years, while the 5 year return sits at 71.3% decline. Recent news around Sarepta Therapeutics has focused on its position...

National Health Investors (NYSE:NHI) is selling its entire skilled nursing facility portfolio for $560 million. The company plans to redeploy proceeds into private-pay senior housing, including a seven-property portfolio in Colorado. This shift reduces exposure to skilled nursing and increases focus on private-pay assets that management views as offering more attractive risk adjusted returns. For investors watching NYSE:NHI, this move comes with the stock recently closing at $75.07 and...

Pacific Biosciences of California (PACB) has just posted its FY 2025 numbers, with Q4 revenue at US$44.6 million and a basic EPS loss of US$0.13 set against trailing twelve month revenue of US$160.0 million and a TTM basic EPS loss of US$1.82. Over the past six reported quarters, the company has seen quarterly revenue move between US$37.2 million and US$44.6 million, while basic EPS has ranged from a small profit of US$0.01 in FY 2024 Q4 to a loss of US$1.44 in FY 2025 Q1. This leaves...

Genius Sports (GENI) opened Q1 2026 with revenue of US$188 million, a basic EPS loss of US$0.21 per share, and net income loss of US$55 million, setting a cautious tone around near term profitability. The company has seen quarterly revenue move from US$144 million in Q1 2025 to US$188 million in Q1 2026, while basic EPS shifted from a loss of US$0.03 to a loss of US$0.21 over the same period. This puts the focus squarely on how efficiently that extra revenue is translating into results. For...

ACADIA Pharmaceuticals (ACAD) opened 2026 with Q1 revenue of $268.1 million and basic EPS of $0.02, against a backdrop of trailing twelve month revenue of $1.1 billion, basic EPS of $2.22 and net income of $375.7 million. Over recent quarters, the company has seen revenue move from $244.3 million in Q1 2025 to $268.1 million in Q1 2026, while quarterly basic EPS has ranged from $0.11 to $1.62. These results come within a period of margin expansion and earnings growth that investors now need...

If you are wondering whether Ouster's share price still offers value after a strong run, it helps to start by lining up the recent returns with what the current valuation really implies. Ouster's stock closed at US$24.51, with returns of 26.8% over 30 days, 4.9% year to date and 183.4% over 1 year, while the last 7 days show a 9.1% decline and the 5 year figure sits at a 70.9% loss. Taken together, these figures suggest investors have been reassessing both potential and risk over different...

This article considers whether Coinbase Global's recent share price suggests a potential bargain or already reflects its current story, by comparing its value against several common yardsticks. At a last close of US$192.96, the stock has returned 2.8% over the past week and 10.1% over the past month. It is down 18.4% year to date and has returned 219.7% over three years and 27.2% over five years. Recent headlines around Coinbase Global have focused on its role as a listed gateway to crypto...

Warner Music Group and Paramount Pictures have agreed a multi year, first look partnership to develop theatrical films based on Warner Music artists and songwriters. The deal focuses on creating new cinema projects that tap into both legendary and contemporary acts from Warner Music Group. This collaboration pairs a major recorded music company with a leading Hollywood studio to build film concepts around music IP. For investors watching NasdaqGS:WMG, this new film partnership sits...

If you are wondering whether Regeneron Pharmaceuticals at around US$709.10 is priced attractively or already reflects the story, the valuation picture is where the answers start to emerge. The stock is up 0.3% over the last 7 days, while it shows a 6.7% decline over 30 days, an 8.7% decline year to date, and a 30.2% return over the past year, which can change how investors think about both upside potential and risk. Recent headlines around Regeneron often focus on its position within large...

Wondering if Donnelley Financial Solutions at around US$44 is offering value or just noise? This article breaks down what the current price might actually mean for you. The stock recently closed at US$44.21, with returns of a 12.1% decline over 7 days, a 10.0% decline over 30 days and a 3.1% decline year to date, alongside a 17.2% decline over 1 year, a 0.2% decline over 3 years and a 73.6% gain over 5 years. Recent coverage of Donnelley Financial Solutions has focused on its role in...

If you are trying to work out whether DraftKings stock looks attractively priced or too expensive at today’s levels, you will want more than just the latest share price in front of you. The stock recently closed at US$25.22, with returns of 8.1% over 7 days and 9.9% over 30 days, while year to date and 1 year returns of negative 29.3% and negative 28.7% show a very different picture over a longer window. Recent headlines around DraftKings have largely focused on the broader US sports betting...

For investors wondering if Krystal Biotech at around US$296.70 is still offering value or if the easy gains are behind it, this article walks through what the current price may be implying. The stock has shown strong share price moves, with returns of 13.1% over 7 days, 12.4% over 30 days, 20.2% year to date, 116.3% over the last year, 228.5% over 3 years, and 374.4% over 5 years. These price moves sit against a backdrop of ongoing attention on Krystal Biotech's position in the...

Gibraltar Industries (ROCK) opened Q1 2026 with total revenue of US$356.3 million and a basic EPS loss of US$0.40, setting a cautious tone around the latest numbers. The company has seen quarterly revenue move from US$246.4 million and EPS of US$0.76 in Q1 2025 through a series of US$309.5 million to US$310.9 million quarters with EPS between US$0.99 and US$1.12, before landing at US$268.7 million and EPS of US$0.40 in Q4 2025. This gives investors a clear look at how the top line has...

MGIC Investment Corporation recently reported its first-quarter 2026 results, with revenue of US$297.08 million and net income of US$165.3 million, both lower than the same period a year earlier. Despite the revenue and profit declines, MGIC’s basic and diluted earnings per share from continuing operations held around US$0.76, indicating stable per-share profitability even as overall earnings softened. Now we’ll examine how this combination of lower revenue but steady earnings per share...

Wondering if Sigma Lithium's current share price reflects its true worth, or if the recent excitement has run ahead of the fundamentals? The stock last closed at US$23.65, with returns of 7.2% over 7 days, 61.7% over 30 days, 66.4% year to date, 218.7% over 1 year and 401.5% over 5 years, while the 3 year return stands at a loss of 40.0%. Recent coverage has focused on Sigma Lithium as a lithium producer, with investors watching how sentiment around the sector and the company's development...

Eversource Energy (ES) opened 2026 with Q1 revenue of about US$4.5 billion and basic EPS of US$1.61, setting the stage against a year of sharply higher trailing earnings and wider margins. Over the last six reported quarters, quarterly revenue has ranged from US$2.8 billion to US$4.5 billion while basic EPS has moved between roughly US$0.20 and US$1.61, and on a trailing twelve month basis EPS reached US$4.69 alongside revenue of about US$13.9 billion. With trailing net margin sitting above...

N-able (NABL) has opened 2026 with Q1 revenue of US$133.7 million and a basic EPS loss of US$0.00, alongside net income excluding extraordinary items of a US$0.6 million loss, setting a mixed tone for the latest results. Over recent quarters the company has seen revenue move from US$118.2 million in Q1 2025 to US$133.7 million in Q1 2026, while basic EPS has shifted between a profit of US$0.01 in Q3 2025 and a larger loss of US$0.04 in Q4 2025 before this latest small loss per share. For...

If you are wondering whether Qnity Electronics at around US$143.59 is richly priced or still offers value, this breakdown outlines what the current share price might be implying. The stock has returned 2.1% over the last 7 days, 20.7% over the past month, and 69.0% year to date, which has put valuation squarely on investors' radar. Recent coverage has focused on Qnity Electronics' position within the semiconductor sector and how investors are reassessing companies tied to data infrastructure...

TKO Group Holdings (TKO) opened 2026 with Q1 revenue of about US$1.6b and basic EPS of US$1.16, alongside trailing 12 month EPS of US$2.84 on revenue of roughly US$5.1b and net income of US$226.35m, setting a clear marker for how the business is currently earning. Over recent quarters, revenue has moved from US$927.92m in Q4 2024 to US$1.27b in Q1 2025 and then to US$1.60b in Q1 2026. Quarterly basic EPS has ranged from US$0.38 in Q4 2024 to US$0.72 in Q1 2025 and US$1.16 in Q1 2026, giving...

If you are wondering whether York Space Systems is fairly priced or offering an opportunity at current levels, the next sections break down what the numbers suggest about value. The stock recently closed at US$33.38, with returns of 0.7% over the past week, 21.1% over the last 30 days, and a small year to date decline of 0.7%. This may catch the eye of investors watching for a turning point in sentiment. Recent attention around York Space Systems has focused on its position in the space and...

Compañía de Minas Buenaventura S.A.A. recently reported first-quarter 2026 results, with revenue of US$624.56 million and net income of US$335.39 million, and its board met on April 29, 2026, to consider appointing Roque Eduardo Benavides Ganoza as Chairman and Shehzad Bharmal as Lead Director. The near doubling of quarterly revenue and earnings compared with a year earlier, alongside potential leadership changes, highlights both operational momentum and evolving governance at the Peruvian...

If you are wondering whether CenterPoint Energy at around US$42.24 is offering good value today, it helps to separate the story, the share price moves and what the numbers actually say. The stock has a 9.1% return year to date, 13.9% over 1 year and 96.0% over 5 years, even though the last 7 and 30 days show returns of 3.2% and 3.1% declines. This means recent moves may feel very different from the longer term picture. Recent coverage has focused on CenterPoint Energy as a regulated utility...

AppLovin (APP) has opened 2026 with Q1 revenue of US$1.8 billion and basic EPS of US$3.57, setting the tone for its latest earnings season update. The company has seen quarterly revenue move from US$1.0 billion in Q4 2024 to US$1.2 billion in Q1 2025 and then to US$1.8 billion in Q1 2026. Basic EPS over the same points stepped from US$1.76 to US$2.13 and then to US$3.57, giving investors a clear view of scaling revenue alongside higher earnings per share as margins stay in focus. See our full...